openPR Logo
Press release

Oligonucleotide Synthesis Market to Touch US$ 770 Mn Valuation by End of 2025

08-24-2018 09:17 AM CET | Health & Medicine

Press release from: Persistence Market Research

Oligonucleotide Synthesis Market to Touch US$ 770 Mn Valuation

Oligonucleotides are short fragments of nucleic acids and play a major role in drug discovery and molecular diagnostic chip technology. Oligonucleotide synthesis occurs either commercially to provide services for various end users or individually via DNA synthesizers for self-consumption. The achievements of life sciences researchers and scientists in the recent years have expanded the understanding of biological systems at the molecular level, which has generated more opportunities and growth in life sciences research and applications. Thus, there are continuous growth opportunities for key players in the global oligonucleotide synthesis market. A new research report by Persistence Market Research titled ‘Oligonucleotide Synthesis Market: Global Industry Analysis 2012 – 2016 and Forecast 2017 – 2025’ presents a complete overview of the global oligonucleotide synthesis market. According to the forecast, the global oligonucleotide synthesis market is expected to reach a market value of over US$ 770 Mn by 2025. The global market is expected to grow at an exceptional rate with a CAGR of 13.9% during the forecast period.

Global Oligonucleotide Synthesis Market: Drivers

Primarily the global oligonucleotide synthesis market is helped by the increase in research activities all over the world. The government is also supporting the research processes taking place especially in the healthcare sector. Government initiatives aimed towards attracting foreign players by providing various grants and subsidies are expected to boost the entry of major market players in emerging countries, thereby driving the regional markets. The market also has a systematic distribution channel that helps in maintaining the proper flow of products in the market, which in turn helps in improving the demand for oligonucleotide synthesis.

Request Sample Report@ https://www.persistencemarketresearch.com/samples/3296

However, the lack of a proper regulatory framework in emerging markets for pharmaceutical and molecular research activities is likely to hamper market revenue growth as the research activities for therapeutic applications of oligonucleotides also need to follow certain regulatory guidelines and absence of these guidelines restricts therapeutic research activities. This is expected to have a negative impact on the oligonucleotide synthesis market.

Global Oligonucleotide Synthesis Market: Segmental Analysis

Based on Region, Asia Pacific is expected to dominate the global oligonucleotide synthesis market with a robust growth rate of 9.8% during the forecast period. However North America is expected to hold the maximum market value during the study period.
Based on Service Type, the custom oligonucleotide synthesis segment is expected to lead the global market during the forecast period.
On the basis of Application, the academic R&D segment dominates the global oligonucleotide synthesis market in terms of revenue with the highest growth rate and revenue share. The academic R&D segment is expected to witness a CAGR of 8.4% during the forecast period.
On the basis of End Users, the academic and research institutes segment dominates the global oligonucleotide synthesis market. The biopharmaceuticals companies segment is also expected to grow at a rate similar to academic and research institutes.

Request TOC@ https://www.persistencemarketresearch.com/methodology/3296

Global Oligonucleotide Synthesis Market: Competition Scenario

This comprehensive research report includes a brief profile of all the major players in the industry. Some of the top companies mentioned in the report include Integrated DNA Technologies, Inc., GenScript Biotech Corporation, Eurofins Scientific SE, Bioneer Corporation, Kaneka Corporation (Eurogentec), Biolegio B.V., Eton Bioscience, Inc., IBA GmbH, Quintara Biosciences, TriLink BioTechnologies, LLC etc.

ABOUT US:
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance. To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

CONTACT:
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Oligonucleotide Synthesis Market to Touch US$ 770 Mn Valuation by End of 2025 here

News-ID: 1198997 • Views:

More Releases from Persistence Market Research

Pediatric Wheelchair Market to Reach to Reach US$ 3.1 Bn by 2031, Growing at 6.3% CAGR
Pediatric Wheelchair Market to Reach to Reach US$ 3.1 Bn by 2031, Growing at 6.3 …
Introduction The pediatric wheelchair market has witnessed significant growth in recent years due to its essential role in enhancing mobility and independence among children with physical disabilities or mobility impairments. Pediatric wheelchairs are designed specifically for children, offering features such as adjustable seating, lightweight frames, customizable supports, and ergonomic designs that cater to growing bodies. These wheelchairs are widely used in hospitals, rehabilitation centers, schools, and home care settings, ensuring safety,
Ablation Catheters Market Set to Grow and Garner a Share of US$ 11.7 Billion by 2031
Ablation Catheters Market Set to Grow and Garner a Share of US$ 11.7 Billion by …
Introduction The ablation catheters market has witnessed significant growth in recent years, driven by the rising prevalence of cardiac arrhythmias and the increasing adoption of minimally invasive procedures. Ablation catheters are specialized medical devices used to treat abnormal heart rhythms by delivering energy to targeted cardiac tissue to restore normal electrical conduction. These devices play a critical role in the treatment of conditions such as atrial fibrillation, ventricular tachycardia, and supraventricular
Endodontic Files Market Expected to Witness Impressive Growth at a 6.7% CAGR by 2031, PMR Report
Endodontic Files Market Expected to Witness Impressive Growth at a 6.7% CAGR by …
Introduction The endodontic files market has witnessed significant growth in recent years, driven by the increasing prevalence of dental disorders, rising awareness of oral health, and advancements in dental technologies. Endodontic files, essential tools in root canal treatments, are used to clean and shape root canals, ensuring effective treatment and preventing infections. These instruments are widely employed in dental clinics, hospitals, and specialized endodontic centers. Their precision, durability, and compatibility with
Bone Growth Stimulator Market To Surge Beyond $3.31 Billion By 2031
Bone Growth Stimulator Market To Surge Beyond $3.31 Billion By 2031
Introduction The bone growth stimulator market has witnessed substantial traction in recent years, driven by the rising prevalence of orthopedic conditions, fractures, and spinal disorders. Bone growth stimulators are medical devices designed to promote bone healing and regeneration through electrical, ultrasonic, or electromagnetic stimulation. These devices play a critical role in reducing recovery time, enhancing bone repair, and improving patient outcomes, particularly in cases of non-union fractures, spinal fusion surgeries, and

All 5 Releases


More Releases for Oligonucleotide

Increasing Cancer Epidemic Driving Growth In The Oligonucleotide Therapy Market: …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Oligonucleotide Therapy Market Size Growth Forecast: What to Expect by 2025? The market size for oligonucleotide therapy has been swiftly expanding in the past few years. Projected growth is from $5.61 billion in 2024 to $6.2 billion in 2025, indicating a compound annual growth rate (CAGR) of 10.5%. The
Oligonucleotide Synthesis Market CAGR 9.9% by 2035, Due To The Growing Demand Fo …
According to our latest market report "Oligonucleotide Synthesis Market by Application Area, Type of Product Synthesized, Type of Oligonucleotide Synthesized, Scale of Operation, Therapeutic Area, End-users, Company Size and Key Geographical Regions: Industry Trends and Global Forecasts, Till 2035", the global oligonucleotide synthesis market size is projected to reach USD 13.5 billion by 2035 from USD 4.8 billion in 2024, growing at a CAGR of 9.9% in the forecast period
Oligonucleotide Synthesis Market Outlook, 2030
The global oligonucleotide synthesis market is set to witness unprecedented growth in the coming decade, driven by advancements in biotechnology, increasing applications in genetic research, and rising demand for personalized medicine. According to market research, the global oligonucleotide synthesis market size was valued at USD 5.198 billion in 2020 and is projected to reach USD 26.09 billion by 2030, growing at a compound annual growth rate (CAGR) of 17.10% from
Antisense Oligonucleotide Therapeutics Market
Antisense Oligonucleotide Therapeutics Market worth $ 64.64 Billion by 2030 - Exclusive Report by Insight Analytics Insight Analytics Pvt. Ltd. announces the release of a market assessment report on the "Global Antisense Oligonucleotide Therapeutics Market- by Therapy (Monotherapy and Combination), Molecule Target Indication (DNA Molecule and RNA Molecule), Target Indication (Duchenne Muscular Atrophy, Spinal Muscular Atrophy, Familial Chylomicronemia Syndrome, Amyotrophic Lateral Sclerosis, Familial Partial Lipodystrophy, Hereditary Transthyretin-Mediated (hatter) Amyloidosis, Huntington's Disease
Oligonucleotide Therapy Market Transforming Healthcare: The Oligonucleotide Ther …
Oligonucleotide Therapy Market worth $19.92 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd. InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Oligonucleotide Therapy Market - (By Type (Antisense, Ribozymes, Aptamers, miRNA, CpG/Immunostimulatory, RNAi), By Application (Infectious Diseases, Oncology, Neurodegenerative Disorders, Cardiovascular Diseases, Kidney Diseases, Others), By End User (Hospitals, Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According
Global Market Study on Oligonucleotide Synthesis: Custom Oligonucleotide Synthes …
Researchmoz added latest report "Global Market Study on Oligonucleotide Synthesis: Custom Oligonucleotide Synthesis Service Type Segment to Hold 70% Market Share by 2025". The industry report lists the leading competitors and provides the insights strategic industry Analysis of the key factors influencing the market. Our new research report on the global oligonucleotide synthesis market gives a brief overview of the global market. The report includes projections on the global oligonucleotide synthesis